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OBJECTIVES: To investigate the association between
proximal colonic neoplasia and distal lesions as a
function of the lesion type. The extent to which health,
demographic, and study characteristics moderate this
association was also examined.
DATA SOURCES: Google Scholar, Web of Science,
Scopus, and PubMed.
STUDY ELIGIBILITY CRITERIA: Studies allowing the
calculation of OR of proximal neoplasia(PN) and proxi-
mal advanced neoplasia (PAN) for distal hyperplastic
polyps (HP), nonadvanced adenomas (NAA), adenomas
(AD), and advanced neoplasia (AN); also, studies for
which the proportions of subjects with isolated (i.e., not
accompanied by distal lesions) PN (IPN) and PAN (IPAN)
over the total number of subjects with PN or PAN could
be calculated.
STUDY APPRAISAL AND SYNTHESIS METHODS:
Thirty-two studies were included for calculating OR
between proximal neoplasia and distal lesions and 40
studies for proportions of IPN and IPAN. Subgroup
analyses were conducted for presence of symptoms,
prevalence of PN and PAN, age, proportion of males,
geographic region, study design, and demarcation point.
RESULTS: The association between distal lesions and
proximal neoplasia increased with the severity of the distal
lesions. Odds of PN were higher in subjects with HP
compared to subjects with a normal distal colon. Odds of
PN and PAN were higher in subjects with NAA, AD, and AN
than in subjects with a normal distal colon. PAN were more
strongly associated with distal lesions in asymptomatic
populations, in young populations, and in populations
with a low prevalence of PAN. In approximately 60% of the
subjects with PN and PAN, these neoplasia were isolated.
LIMITATIONS: The present results may be affected by
publication bias and dichotomization in the subgroup
analyses. Limitations related to the individual studies
include self-selection, lesion misclassification and
misses, and technological advances leading to changes
in the detection of lesions during the time span of the
included studies.
CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS:
All types of distal lesions are predictive of PN. All types of
distal neoplasia are predictive of PAN. The association
between distal lesions and proximal neoplasia increases
with the severity of the distal lesion. The association
between distal lesions and proximal advanced neoplasia
is stronger in low-risk groups as compared to high-risk
groups.
KEY WORDS: cancer screening; colorectal cancer; systematic review.
J Gen Intern Med 27(3):361–70
DOI: 10.1007/s11606-011-1919-y
© The Author(s) 2011. This article is published with open access at
Springerlink.com
INTRODUCTION
The use of flexible sigmoidoscopy followed by colonoscopy in
colorectal cancer screening programs relies on the assumption
that distal lesions are reliable markers of proximal neoplasia. It
is widely established that subjects with distal advanced
neoplasia (AN) have increased odds of proximal neoplasia (PN)
and proximal advanced neoplasia (PAN).
1–3
Whether distal hyperplastic polyps (HP) are also markers of PN
and PAN is debatable. Formal guidelines generally do not consider
HP to be markers of PN or PAN.
3–5 Seven of nine colonoscopy
studies published to date revealed no significant associations
between HP and PN,
6–14 and only one of eight colonoscopy
studies reported a significant association between HP and
PAN.
6,10,15–20 Pathology studies, however, suggest that HP could
develop into cancer through microsatellite instability and hyper-
methylation pathways.
21–25 The published pathological evidence
has been suggested as one of the reasons why physicians tend
not to adhere to formal guidelines and refer patients with HP
alone for colonoscopy.
26 The association between distal non-
advanced adenomas (NAA) and PN and PAN is equivocal as well,
and screening recommendations leave the follow-up program for
subjects with NAA to the judgment of the clinician.
3,27,28
The effectiveness of flexible sigmoidoscopy for screening not
only depends on whether distal lesions are markers of PN or
PAN, but also on the PN and PAN that are isolated, that is, not
accompanied by distal lesions (IPN and IPAN, respectively). It
has been suggested that in about half of the subjects, PN do not
have distal markers and are thus not identifiable by the
sigmoidoscopy outcome alone.
16,18,29 It has further been shown
that the prevalence of IPN is higher in subjects older than
60 years, those with a family history of colorectal cancer, and
those with 10 pack-years of smoking.
30
Three previous meta-analyses
31–33 have summarized the
empirical evidence regarding the association between distal
lesions and proximal neoplasia. Subjects with HP had higher
odds of PN compared to subjects having a normal distal colon,
33
and subjects with NAA were more likely to also have PN than
subjects without distal neoplasia.
32 Neither HP
31,33 nor NAA
32
appeared to increase the odds of PAN. These past meta-analyses
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361need to be updated, however. A large number of relevant studies
have been published since, offering the opportunity for a more
powerful synthesis. Furthermore, the previous meta-analyses
did not summarize the effects of demographic factors, such as
age, gender, or geographic region, which show differential effects
on the prevalence of colonic lesions.
34,35 It is possible that the
association between distal lesions and proximal neoplasia is
also sensitive to these factors. Lastly, the existing meta-analyses
did not investigate the extent to which demographic factors
moderate the proportions of subjects with IPN and IPAN.
The aim of this meta-analysis was to investigate the relation-
ship between distal lesions and proximal neoplasia as a function
of lesion type, to estimate the proportion of subjects with
isolated proximal neoplasia in the population, and to examine
the extent to which health, demographic, and study character-
istics are moderators of the association between distal lesions
and proximal neoplasia and of the proportions of subjects with
isolated proximal neoplasia.
METHOD
A literature search was carried out between 11 and 26
November 2010 using Google Scholar, Web of Science, Scopus,
and PubMed. Each of the terms “proximal neoplasia”, “advanced
proximal neoplasia”, “proximal advanced neoplasia”, “proximal
neoplasms”,a n d“proximal adenoma” was combined with each
of the terms “distal”, “hyperplastic”, “adenoma”, “nonadvanced”,
“advanced”, “sigmoidoscopy”,a n d“colonoscopy” in a full-text
search.
Exclusion Criteria
The following types of studies were excluded:
& Studies in which subjects with a positive sigmoidoscopy
outcome were referred to colonoscopy. These studies either
lacked subjects with a normal distal colon to be used as a
reference, or used as a reference subjects whose distal
biopsies were found to consist of normal mucosa during
histological examination conducted after colonoscopy.
& Studies focusing on patient groups with colorectal cancer,
inflammatory bowel disease, hyperplastic polyposis syn-
drome, hereditary nonpolyposis syndrome, diverticulosis,
or HIV.
& Studies including only subjects younger than 50 years, as
these subjects have lower odds of colorectal lesions as
compared to subjects that are 50 years and older, who are
the typical target group of screening programs.
36,37
& Studies in which nonneoplastic proximal lesions were
aggregated together with neoplastic ones, and studies
reporting only proximal cancer.
& Studies focusing on subjects who underwent polypectomy.
& Studies with internal inconsistencies inhibiting the calcu-
lation of odds ratios.
& Studies in languages other than English.
Data Extraction
The following data were collected from each study: sample size,
presence or absence of symptoms (including a positive fecal
occult blood test or barium enema) in more than 50% of the
population, mean age, proportion of male subjects, Western
(American or European) or Eastern (Asian) population, pro-
spective or retrospective study design, and demarcation point
of distal colon (splenic flexure, 60-cm sigmoidoscope length, or
rectosigmoid). An e-mail was sent to the corresponding
authors of the studies with missing demographic data.
Thirty-two studies met the criteria described in the previous
section. Twenty-nine studies classified subjects with respect to
their most advanced distal lesion. Of the remaining three
studies, one provided the number of all distal lesions per
subject and the other two included a group of subjects with
mixed hyperplastic and adenomatous polyps. We classified the
subjects in these three studies based on their most advanced
distal lesion.
Twenty-eight studies reported the number of subjects per
type of distal lesion without distinguishing between single and
multiple lesions, whereas the remaining four reported subjects
with single and multiple lesions separately. It has previously
been shown that multiple distal lesions are associated with
increased odds of proximal neoplasia compared to single
lesions of the same type.
38,39 To conform with the methodology
followed by the majority of the studies included, however, in
these four studies we clustered the subjects with single and
multiple lesions together and classified them according to the
type of their lesions only.
OR of PN and PAN were calculated for the following distal
lesions: hyperplastic polyps (HP), nonadvanced adenomas (NAA),
adenomas (AD), and advanced neoplasia (AN). AN were defined as
adenomas with a size of 10 mm or greater, adenomas with villous
portions, high-grade dysplasias, and adenocarcinomas. Non-
hyperplastic lesions were considered as normal findings. OR
were calculated as the number of subjects with PN (or PAN) in the
group of subjects with distal lesions compared to the number of
subjects with PN (or PAN) in the reference group. OR of HP were
calculated with the subjects having a normal distal colon as the
reference group. OR of NAA, AD, and AN were calculated by using
two reference groups: subjects with a normal distal colon, as in
Lin et al.,
33 and subjects with no distal neoplasia, as in Lewis et
al.
32 The results were not statistically different. The percentual
differences in the summary OR (defined as the absolute differ-
ence of the two summary OR divided by the summary OR with
the normal-distal-colon group as reference) were: NAA–PN=
5.9%, AD–PN=−1.4%, AN–PN=−3.6%, NAA–PAN=18.9%, AD–
PAN=−0.2%, and AN–PAN=19.5%. The summary OR presented
herein are based on a combination of the two reference
groups: the subjects with a normal distal colon were used
as the reference group; when this group was not available in a
study, the reference group consisted of the subjects with no
distal neoplasia instead. OR were not calculated when zero
events were observed. OR were meta-analyzed using the
random-effects Mantel-Haenszel method.
Absolute risks (AR) of PN and PAN were calculated for subjects
with a normal distal colon, HP, NAA, AD, and AN. The absolute
risk of PN (or PAN) for subjects with a certain distal-colon
condition (i.e., normal, HP, NAA, AD, or AN) was defined as the
percentage of subjects with PN (or PAN) and this distal-colon
condition out of the total number of subjects with this condition.
Proportions of IPN or IPAN were defined as the number of
subjects with IPN or IPAN over the total number of subjects with
PN or PAN. AR and proportions of IPN and IPAN were meta-
analyzed using the DerSimonian-Laird random-effects method.
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were conducted according to the presence or absence of
symptoms, age younger than 60 years versus 60 years or older,
proportion of males lower versus equal to or higher than 0.5,
study conducted in Western or Eastern region, prospective or
retrospective study design, and splenic flexure or rectosigmoid
used as demarcation point. Subgroup analysis of OR was also
conducted for PN and PAN prevalence lower versus equal to or
higher than the median PN and PAN prevalence. A z-test was
used to compare the summary odds ratios between sub-
groups.
40 To investigate the possibility of publication bias the
asymmetry of the funnel plots was assessed by Egger’s test.
RESULTS
The literature search yielded 2320 titles (Fig. 1). After exclud-
ing 748 duplicates within and among databases, 1572
abstracts were reviewed. Of these, 1324 were excluded based
on the criteria described in the method section. The full texts of
the remaining 248 publications were reviewed. Thirty-two
publications fulfilled the criteria and were included in the
meta-analysis (Table 1).
Figure 2 illustrates the sample size and the number of times
each of the 32 studies was included in past meta-analyses as a
function of the publication year. A significant positive correla-
tion was found between publication year and sample size (r=
0.49, p=0.005). A shift from prospective towards retrospective
studies can also be observed, but without reaching signifi-
cance (r=0.28, p=0.122). Of the eight studies published before
2005 but not included in the most recent meta-analysis,
33
six
38,41,42,46,49,51 were not taken into consideration probably
because they did not provide data on HP, one
54 was excluded
on the grounds that it did not provide suitable HP data, and
one
55 was not mentioned. We used the first seven stud-
ies
38,41,42,46,49,51,54 to estimate the association between AD
and PN/PAN.
Table 2 shows the summary estimates of AR and OR for the
association between distal lesions and proximal neoplasia. The
odds of PN were higher in subjects with HP compared to those
having a normal distal colon. Subjects with HP did not show
evidence of increased odds of PAN. Note that only 2 of the 9
included studies yielded a significantly positive association
between HP and PN. Absolute risks and odds of both PN and
PAN were higher in subjects with NAA, AD, and AN than in
subjects having a normal distal colon. A positive trend between
the association of distal and proximal lesions and the severity
of the distal markers can be noticed.
In order to estimate the proportions of IPN and IPAN, a
literature search was conducted using the terms “isolated
proximal” and “sigmoidoscopy” in Google Scholar, Web of
Science, Scopus, and PubMed. A manual review of the
references in each newly retrieved and selected article was
also performed. Eight additional studies were identified in this
way.
Figure 3 shows the proportions of IPN and IPAN per study.
The random-effects summary estimates were 0.61 (95% CI=
0.55–0.67) and 0.58 (95% CI=0.53–0.63) for IPN and IPAN,
respectively. In the population, these proportions correspond
1572 abstracts reviewed
1324 citations exluded as:
Irrelevant
Non-English studies
Overviews/reviews/guidelines/opinion articles/indexes
Diseases (e.g., HIV, inflammatory bowel disease)
Only subjects younger than 50 years
2320 titles retrieved
1102 from Google Scholar
301 from Web of Science
850 from Scopus
67 from PubMed
748 citations exluded as duplicates among/within databases
248 full text articles reviewed
2 1 6c i t a t i o n se x l u d e da s :
Overviews/reviews/guidelines/opinion articles/indexes
Sigmoidoscopy studies
Nonneoplastic proximal lesions summed with neoplastic ones
Only proximal cancer and no other proximal lesions reported
No data to calculate odds ratios
Internally inconsistent resuts
32 included in the analysis
Figure 1. Flow diagram of study selection.
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IPN and 0.02 (95% CI=0.01–0.03) for IPAN.
Table 3 shows the OR after splitting the studies according to
the presence of symptoms, prevalence of PN and PAN, age,
proportion of males, geographic region, study design, and
demarcation point of the distal colon.
Symptoms and prevalence of proximal neoplasia. Symptomatic
populations with NAA showed higher odds of PN compared to
asymptomatic populations. For PAN, the opposite effect held,
with NAA and AN being stronger predictors in asymptomatic
populations. Moreover, the association between AN and PAN
was stronger in populations with a PAN prevalence lower than
the median PAN prevalence of all populations for which PAN
prevalence could be calculated.
Age and gender. AN were more strongly associated with PAN in
younger populations. No other subgroup differences based on
age or gender were found. To gain a better understanding of the
moderating role of age, an additional subgroup analysis was
conducted for the studies for which OR could be calculated
separately for subjects younger than 50 years versus 50 years or
older, and found that the OR for AN–PN and NAA–PAN were
significantly higher for the subgroups of younger subjects
(Table 4).
Geographic region. The NAA–PAN association was stronger in
Western regions than in Eastern ones.
Study design. No differences were found between the OR of
prospective and retrospective studies.
Demarcation point. The definition of demarcation point did not
affect the OR of PN. Note, however, that the number of studies
was limited. Odds ratios between NAA/AN and PAN were
significantly higher in studies using the splenic flexure as the
Table 1. Characteristics of the Studies Included in the Meta-Analysis
Reference Sample size Symptoms Mean age
(years)
Proportion
male
Geographic
region
Demarcation
point
Study
design
1 Ang et al. 2002
41 * 450 Yes 71.0 0.45 0 0 1
2 Betés Ibáñez et al. 2004
42 2210 No 57.9 0.75 0 0 1
3 Binda et al. 2007
6 * 830 Yes 65.0 0.41 0 0 1
4 Brady et al. 1993
7 162 No 62.0 0.76 0 1 0
5 Byeon et al. 2007
15 860 No 54.4 0.55 1 0 0
6 Choe et al. 2007
43 * 2435 No 57.7 0.67 1 0 1
7 Chung et al. 2006
44 1541 Yes 55.1 0.52 1 2 1
8 Erarslan et al. 2009
45 1064 No 66.0 0.38 0 0 1
9 Foutch et al. 1991
8 129 No 64.0 0.98 0 1 0
10 Hammer et al. 2000
38 3268 Yes 68.0** 0.49 0 0 0
11 Ikeda et al. 2000
46 3131 No 51.9 1.00 1 0 1
12 Imperiale et al. 2003
16 3025 No 59.8 0.58 0 0 1
13 Johnson et al. 1990
47 88 No 65.0 0.68 0 0/2 0
14 Kadakia et al. 1996
48 175 No 65.0 0.61 0 0 0
15 Khan et al. 2003
49 1301 No 65.7 0.70 0 2 1
16 Leung et al. 2005
17 4646 Yes 55.0 0.50 1 0 0
17 Lieberman & Smith 1991
9 105 No 64.0 1.00 0 1 0
18 Lieberman et al. 2000
18 3118 No 62.9 0.97 0 0/2 0
19 Lin et al. 2005
10 * 2188 No 60.7 0.49 0 0/2 0
20 Liou et al. 2007
19 2106 No 59.4 0.57 1 0 1
21 Liu et al. 2005
20 5973 No 56.6 0.63 1 0 0
22 Nicholson et al. 2000
50 1131 No 54.0 0.63 0 0 1
23 Odelowo et al. 2002
51 5514 No 65.1 — 00 1
24 Okamoto et al. 2005
52 6196 Yes 60.1 0.65 1 2 0
25 Park et al. 2009
53 3951 No 52.1 0.60 1 0 0
26 Pennazio et al. 1993
11 216 Yes 64.0 0.67 0 2 1
27 Provenzale et al. 1988
12 514 Yes — 0.51 0 2 1
28 Provenzale et al. 1990
13 970 Yes — 0.47 0 2 0
29 Rex et al. 1992
14 482 No 62.5 — 02 0
30 Sciallero et al. 1997
54 3088 Yes 59.9 0.55 0 2 1
31 Strul et al. 2006
37 * 917 No 60.9 0.48 0 0/2 1
32 Thiis et al. 1999
55 193 No 67.4 0.56 0 2 0
Additional studies included in the IPN and IPAN analysis
33 Al-Enezi et al. 2010
56 530 No 45.0 0.66 1 0 1
34 Castiglione et al. 1995
57 2937 Yes —— 02 1
35 Chiu et al. 2005
58 1846 No 52.5 0.60 1 0 0
36 Gryska et al. 1987
59 49 No 54.5 — 02 1
37 Kim et al. 2007
60 4491 No 48.4 0.53 1 0 1
38 Lieberman et al. 1988
61 98 Yes 65.0 0.94 0 1 1
39 Schoenfeld et al. 2005
62 1463 No 58.9 0.00 0 0 0
40 Soon et al. 2008
63 1382 No 58.8 0.60 1 0 1
*Only the subjects that were 50 years or older have been included in the analysis
**Median age
Geographic region: Western (American or European)=0; Eastern (Asian)=1. Demarcation point: Splenic flexure=0; 60 cm (length of sigmoidoscope)=1;
Rectosigmoid=2. Study design: Prospective=0; Retrospective=1
Abbreviations: IPAN, isolated proximal advanced neoplasia; IPN, isolated proximal neoplasia
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using the rectosigmoid as demarcation. Figure 4 illustrates this
effect for the association between AN and PAN.
Subgroup analyses were also conducted for proportions of
IPN and IPAN. None of the investigated factors (presence of
symptoms, age, proportion of males, geographic region, study
design, and demarcation point) was found to be a moderator of
these proportions.
To investigate the possibility of publication bias the
asymmetry of the funnel plots was assessed by Egger’s test. A
slight bias inflating the association between PN and AN was
found (intercept (95% CI)=−2.92 (−5.67, −0.17), p=0.041).
Because the PN–AN association is strong and generally
accepted, however, we do not consider this finding to be of
clinical significance. In all other lesion associations and
proportions of IPN and IPAN the funnel plot asymmetry was
not significant.
COMMENT
The relationship between distal lesions and proximal neoplasia.
This article provided a meta-analysis of the relationship
between distal lesions and proximal neoplasia as a function
of lesion type. Thirty-two studies were retrieved providing
information suitable for calculating odds ratios for PN and
PAN. Concerning PAN, 18 studi e sw e r ei n c l u d e d ,w h i c h ,
compared to the two studies available in past meta-
analyses, resulted in more precise estimates of the
summary effects. Forty studies were included for analyzing
proportions of IPN and IPAN. The extent to which health,
demographic, and study characteristics moderate the
association between distal lesions and proximal neoplasia
as well as the proportions of IPN and IPAN was also
examined.
Subjects with HP showed higher odds of PN compared to
subjects having a normal distal colon, whereas they did not
show evidence of increased odds of PAN, in line with Lin et
al.
33 Subjects with NAA showed higher odds of both PN and
PAN, supporting and extending Lewis et al.
32 who found a
significant association between NAA and PN and “potential
evidence” (p. 418) but not a significant association between
NAA and PAN. Note that Lewis et al.
32 focused on “diminutive
adenomas”, but the term had multiple definitions and we
believe that the term corresponds better to NAA.
Health characteristics. PANwerebetter predictedinasymptomatic
populations, young populations, and populations with a low PAN
prevalence; that is, in low-risk groups. This supports past
evidence showing that subjects diagnosed at a young age are
more likely to have advanced malignancies, possibly due to
genetic predispositions.
64,65
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Figure 2. Scatter plot of studies per year of publication as a function of sample size and study design. Abbreviations: MA, meta-analysis.
Table 2. Summary Estimates of Absolute Risks (%) and Odds Ratios of
PN and PAN in Subjects with Distal HP, NAA, AD, and AN
N* AR (95% CI) OR (95% CI)
PN Normal distal 13 14.8 (10.1–20.3) —
HP 9 (2) 27.2 (17.6–38.0) 1.8 (1.3–2.5)
NAA 11 (9) 28.1 (23.0–33.5) 2.6 (2.1–3.3)
AD 16 (12) 29.7 (25.0–34.6) 3.8 (3.1–4.6)
AN 8 (6) 32.8 (27.0–38.9) 3.4 (2.4–4.9)
PAN Normal distal 12 1.9 (1.4–2.4) —
HP 8 (1) 2.3 (1.6–3.2) 1.2 (0.8–2.0)
NAA 17 (10) 5.2 (3.2–7.6) 2.1 (1.7–2.5)
AD 11 (8) 8.3 (4.8–12.7) 3.1 (2.2–4.3)
AN 14 (12) 14.5 (11.6–17.6) 5.8 (4.0–8.6)
*Numbers in brackets indicate the studies for which the calculated
association was significantly positive at the 0.05 level
Odds ratios of HP were calculated with the subjects having a normal
distal colon as reference. For the odds ratios of NAA, AD, and AN, the
subjects with a normal distal colon were used as reference; when this
group was not available, the reference consisted of the subjects with no
distal neoplasia
Abbreviations: AD, adenomas; AN, advanced neoplasia; HP, hyperplastic
polyps; N, number of studies; NAA, nonadvanced adenomas; PAN,
proximal advanced neoplasia; PN, proximal neoplasia
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have a higher and earlier risk of colonic neoplasia than
women.
6,10,11,20,35,42–44,52,53,58,66–71 Age and gender are
interacting factors, with women younger than 50 years having
a lower risk of proximal than distal neoplasia, while males in the
same age group have a higher prevalence of distal than proximal
neoplasia,
16,65,72 women between 50 and 70 years showing an
increasing incidence of proximal neoplasia compared to women
of younger age,
62,65,69 and gender differences diminishing after
the age of 70.
62 With respect to geographic region, it has been
suggested that although Eastern populations have fewer
incidences of isolated proximal neoplasia, lesions that are more
likely distal,
8,38,44,45,73–76 and a 10-year delay in the incidence of
colonic neoplasia,
43 Western and Eastern populations are
becoming increasingly comparable due to the Westernization of
the Eastern lifestyle. Note that the existing information concerns
prevalences. We found no differences between genders and
geographic regions regarding the association between distal
lesions and proximal neoplasia.
Study design characteristics. The study of Lin et al.,
33 the
only meta-analysis investigating the moderating effect of the
demarcation point of the distal colon, reported no clinically
significant differences in lesion associations between
studies using a different demarcation point. We found that
studies using the splenic flexure as demarcation yielded
significantly higher OR between NAA/AN and PAN compared
to studies using the rectosigmoid as demarcation. Note that
the majority of the colonoscopy studies used the splenic
flexure as the demarcation point, but this does not reflect
clinical practice, in which the sigmoidoscope may not reach
the area beyond the rectosigmoid in more than 60% of
procedures.
77,78 The association between NAA/AN and PAN
is thus likely weaker in a screening setting than the
estimates provided in studies using the splenic flexure as
demarcation.
Proportions of IPN and IPAN. The summary estimates of
percent proportions of subjects with IPN and IPAN were about
60%, which is higher than the estimates of about 50%
provided in past meta-analyses. We found no subgroup
differences of demographic factors for proportions of either
IPN or IPAN. Note that our analysis concerned the proportion
of subjects with IPN and IPAN, and not the population
prevalence of IPN and IPAN which is affected by the general
prevalence of PN and PAN (i.e., accompanied by distal lesions
or not). That is, the increasing population prevalence of IPN
with age reported in previous studies
30,79 is due, at least in
part, to the increasing prevalence of proximal/colonic neoplasia
with age, no matter whether the proximal neoplasia are isolated
or not.
Study Limitations
Self-selection. A number of biases may have affected the results
of the meta-analysis. First, the subjects in the studies were
likely to be more health-conscious and aware of preventive
medicine than the general population.
9,15,37,42,55,80,81 Moreover,
32 Brady 1993
31 Pennazio 1993
30 Foutch 1991
29 Gryska 1987
28 Al−Enezi 2010
27 Kadakia 1996
26 Castiglione 1995
25 Hammer 2000
24 Thiis 1999
23 Park 2009
22 Sciallero 1997
21 Kim 2007
20 Lieberman 1991
18 Lieberman 1988
17 Binda 2007
16 Chung 2006
15 Nicholson 2000
14 Lin 2005
13 Rex 1991
12 Strul 2006
11 Choe 2007
10 Chiu 2005
 9 Ikeda 2000
 8 Odelowo 2002
 7 Ang 2002
 6 Soon 2008
 5 Khan 2003
 4 Provenzale 1988
 3 Johnson 1990
 2 Schoenfeld 2005
 1 Provenzale 1990
Summary proportion
0 0.2 0.4 0.6 0.8 1
IPN
 0.12 (0.04−0.26)
 0.15 (0.08−0.26)
 0.34 (0.19−0.53)
 0.36 (0.19−0.55)
 0.39 (0.24−0.56)
 0.39 (0.25−0.55)
 0.41 (0.37−0.46)
 0.50 (0.45−0.55)
 0.51 (0.35−0.68)
 0.52 (0.46−0.58)
 0.56 (0.51−0.61)
 0.56 (0.51−0.61)
 0.56 (0.36−0.74)
 0.57 (0.29−0.82)
 0.58 (0.37−0.77)
 0.61 (0.52−0.69)
 0.63 (0.57−0.68)
 0.64 (0.50−0.77)
 0.64 (0.58−0.70)
 0.66 (0.56−0.76)
 0.69 (0.58−0.78)
 0.71 (0.66−0.75)
 0.71 (0.62−0.80)
 0.74 (0.70−0.79)
 0.75 (0.71−0.78)
 0.77 (0.50−0.93)
 0.80 (0.70−0.87)
 0.85 (0.78−0.90)
 0.87 (0.80−0.91)
 0.91 (0.59−1.00)
 0.92 (0.79−0.98)
 0.93 (0.89−0.96)
 0.61 (0.55−0.67)
19 Park 2009
18 Lieberman 2000
17 Betés Ibáñez 2004
16 Hammer 2000
15 Eraslan 2009
14 Imperiale 2003
13 Okamoto 2005
12 Liou 2007
11 Leung 2005
10 Choe 2007
 9 Liu 2007
 8 Thiis 1999
 7 Chung 2006
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Figure 3. Forest plots with proportions of isolated proximal neoplasia (IPN, left) and isolated proximal advanced neoplasia (IPAN, right)
defined as the number of subjects with IPN or IPAN over the total number of subjects with PN or PAN. The error bars are depicted at the 95% CI.
The area of the squares corresponds to the weight of each study in the random-effects model. Note that some studies provided data that
allowed the calculation of proportions of both IPN and IPAN. The variance of true effect sizes τ
2 was 0.118 and 0.035 for IPN and IPAN,
respectively.
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medical centers in urban areas,
19,53 or in private clinics
requiring private health insurance
42,82 and compensations
as high as $500,
19 possibly contributing to self-selection
bias.
Misclassification and misses. Other sources of bias are lesion
misses, false positives, and lesion misclassification. Miss
rates of about 26% and 13% of adenomas smaller than
5 mm and between 5 and 10 mm, respectively, have been
reported.
83,84 Small adenomas may be misclassified as
HP,
85,86 and adenomatous changes in a portion of HP may
not be noticed without histological examination. Moreover,
endoscopists usually compare the size of polyps to the width of
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Figure 4. Scatter plot of the odds ratio for the association between
distal advanced neoplasia (AN) and proximal advanced neopla-
sia (PAN) versus the PAN prevalence for studies using the splenic
flexure or the rectosigmoid as the demarcation point of the distal
colon. The area of the circles represents the sample size of each
study. The size of the circles in the legend corresponds to a sample
size of 1000.
Table 4. Subgroup Analysis for Age Younger than 50 years Versus
50 years or Older of the Summary Odds Ratios of PN and PAN in
Subjects with Distal NAA and AN
NAA AN
N OR (95% CI) N OR (95% CI)
Age <50 years PN 2* 3.2 (1.5–6.6) 2
‡ 6.8 (3.2–14.5)
≥50 years 6
† 2.0 (1.6–2.5) 4
§ 2.8 (2.0–3.9)
<50 years PAN 3
‖ 6.9 (2.6–18.3) 1
# —
≥50 years 7
¶ 2.3 (1.6–3.4) 5
** 5.9 (3.4–10.3)
* References: 6, 43;
† References: 6, 7, 37, 43, 47, 55;
‡ References: 6, 43;
§ References: 6, 37, 43, 55;
‖ References: 6, 36, 43;
¶ References: 6, 16,
18, 19, 43, 47, 55;
# Reference: 36; ** References: 6, 16, 18, 43, 55
A z-test was used to compare the summary odds ratios between
subgroups. p<0.05 are annotated in bold
Abbreviations: AN, advanced neoplasia; NAA, nonadvanced adenomas;
PAN, proximal advanced neoplasia; PN, proximal neoplasia
Table 3. Subgroup Analysis for Health, Demographics, and Study Characteristics of the Summary Odds Ratios of PN and PAN in subjects with
Distal HP, NAA, and AN
HP NAA AN
N OR (95% CI) N OR (95% CI) N OR (95% CI)
Health characteristics
Symptoms No PN 5 1.4 (1.0–1.9) 7 2.1 (1.7–2.6) 5 3.3 (2.3–4.6)
Yes 4 2.4 (1.3–4.3) 4 3.2 (2.5–4.2) 3 3.8 (2.0–7.3)
No PAN 6 1.3 (0.8–2.1) 12 2.5 (2.0–3.1) 9 8.1 (5.3–12.2)
Yes 2 0.8 (0.1–4.3) 5 1.7 (1.3–2.2) 5 3.9 (2.4–6.4)
Prevalence PN Low (<0.147) PN 1 — 5 2.6 (1.8–3.7) 4 3.5 (1.8–6.6)
High (≥0.147) 8 1.9 (1.3–2.8) 6 2.6 (1.8–3.7) 4 3.3 (2.4–4.5)
Prevalence PAN Low (<0.025) PAN 5 1.3 (0.6–2.8) 7 2.0 (1.4–2.8) 5 9.9 (5.6–17.4)
High (≥0.025) 3 1.1 (0.6–2.2) 10 2.1 (1.6–2.8) 9 4.9 (3.3–7.3)
Demographic characteristics
Age <60 years PN 0 — 3 2.2 (1.6–3.1) 3 3.4 (2.4–4.9)
≥60 years 8 1.5 (1.1–2.0) 8 3.0 (2.4–3.8) 5 3.3 (1.8–6.0)
<60 years PAN 5 1.3 (0.6–2.8) 10 2.3 (1.9–2.9) 8 8.1 (5.1–13.0)
≥60 years 3 1.0 (0.6–1.7) 7 1.8 (1.3–2.4) 6 3.6 (2.1–6.2)
Gender <50% males PN 3 1.4 (1.1–2.0) 3 2.9(2.1–4.0) 3 3.9 (1.9–8.0)
≥50% males 5 2.5 (1.4–4.5) 8 2.5 (1.9–3.4) 5 3.2 (2.4–4.2)
<50% males PAN 2 1.1 (0.4–2.5) 2 1.9 (1.2–3.1) 2 4.7 (1.7–13.3)
≥50% males 6 1.2 (0.7–2.3) 15 2.1 (1.7–2.6) 12 6.0 (3.9–9.4)
Geographic region Western PN 9 1.8 (1.3–2.5) 8 3.0 (2.4–3.8) 5 3.3 (1.8–6.0)
Eastern 0 — 3 2.2 (1.6–3.1) 3 3.4 (2.4–4.9)
Western PAN 4 1.2 (0.8–1.9) 8 2.5 (1.9–3.3) 7 6.0 (4.1–8.8)
Eastern 4 1.0 (0.3–3.4) 9 1.7 (1.4–2.1) 7 6.2 (3.5–11.3)
Study characteristics
Study design Prospective PN 6 1.4 (1.1–1.9) 4 3.1 (1.9–4.9) 2 4.9 (1.9–12.5)
Retrospective 3 2.8 (1.3–6.3) 7 2.4 (1.9–3.1) 6 3.1 (2.5–3.9)
Prospective PAN 5 1.2 (0.6–2.4) 9 1.9 (1.5–2.5) 7 5.6 (3.2–9.6)
Retrospective 3 1.2 (0.5–2.7) 8 2.2 (1.7–3.0) 7 6.1 (3.5–10.9)
Demarcation point Splenic flexure PN 2 1.4 (1.0–2.0) 6 2.3 (1.7–2.9) 5 3.8 (2.4–6.1)
Rectosigmoid 4 2.3 (1.2–4.5) 4 3.2 (2.4–4.2) 3 2.9 (2.2–3.9)
Splenic flexure PAN 8 1.2 (0.8–2.0) 13 2.4 (2.0–2.9) 10 7.8 (5.8–10.5)
Rectosigmoid —— 4 1.5 (1.1–1.9) 4 2.6 (2.2–3.1)
A z-test was used to compare the summary odds ratios between subgroups. p<0.05 are annotated in bold
Abbreviations: AN, advanced neoplasia; HP, hyperplastic polyps; NAA, nonadvanced adenomas; PAN, proximal advanced neoplasia; PN, proximal
neoplasia
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of polyp size.
87,88
Dichotomization. The subgroup analyses relied on dichotomized
age, gender, and PN/PAN prevalence groups. This approach may
have led to power loss and reduced measurement reliability.
89
Technological advances. The included studies spanned more
than two decades. Technical advances in colonoscopy, such as
high-definition imaging
90,91 and optimization of withdrawal
techniques
92–94 have improved the detection of lesions,
particularly of those between 0 and 5 mm.
93 The analyses
were repeated separately for the studies published before or
after 2000 and before or after 2005 and no statistically
significant differences in the reported odds ratios and
proportions of IPN and IPAN were found.
CONCLUSION
The present results are important for identifying persons who
may need to undergo a colonoscopy. We found that all types of
distal lesions are predictive of proximal neoplasia and that PAN
are better predicted by distal lesions in low-risk groups. The
association between distal lesions and proximal neoplasia
increased with the severity of the distal lesion. The fact that
more than half of the proximal neoplasia are isolated urges the
investigation of other risk factors, including genetic predispo-
sition and environmental risks, which could contribute to
predicting proximal neoplasia.
Although a number of screening programs employ colo-
noscopy, flexible sigmoidoscopy will probably gain territory in
view of the results of four large-scale randomized clinical
trials of screening flexible sigmoidoscopy performed in Nor-
way (NORCCAP),
95 the UK (UKFSST),
96 Italy (SCORE),
97 and
the US (PLCO).
98 NORCCAP reported a reduction of 76% for
distal colorectal cancer, and in UKFSST the incidence of
colorectal cancer was reduced by 33% and the corresponding
mortality by 40% (see also
99 for a review and meta-analysis).
UKFSST found no effect of screening on the incidence of
proximal cancer. It remains to be observed whether a
reduced incidence of colorectal cancer and corresponding
mortality will occur in the other two trials, in which the
criteria for colonoscopy referral are closer to those in the
present meta-analysis.
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